{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Breaking Precedent","title":"Breaking the Capital Ceiling: Erin Harkless Moore on Who Gets Funded and Why","html":"","width":"100%","height":180,"duration":3833,"description":"What happens when a $648 billion market goes uncounted, and who decided it wasn't worth measuring in the first place?\n\nThis episode follows Erin Harkless Moore from the breakfast table in San Antonio, through Goldman Sachs, Cambridge Associates, and Princeton's endowment, to Pivotal, the organization founded by Melinda French Gates, where she builds an investment program aimed at the people and markets capital has overlooked. It's a conversation about who gets funded, who gets to decide, and what changes when you start measuring what finance has ignored.\n\nLeah Solivan interviews Erin about starting her career in a Goldman Sachs group with no female partners, earning the CFA so no one could question her technical credibility, and cold-emailing Harvard Business School alumni to find her way to the allocator side of the table. She shares the index card her husband pushed her to write, a single line about changing how capital is allocated and who is in the room, and how it led to a job she half-thought was a prank, interviewing virtually as Seattle became an early COVID epicenter.\n\nErin explains why reframing the bar isn't the same as lowering it, using the example of GP commitment requirements that can screen out fund managers who don't come from wealth. She walks through Pivotal's approach of using investing, philanthropy, and advocacy together, how DEI headwinds are showing up in fundraising right now, what she has learned from watching Melinda French Gates prepare for every meeting, and where she sees the next overlooked markets, from women's health to women's sports.\n\nShe closes with what she'd write on the index card for the next generation of women building where capital hasn't looked yet.\n\nKey Insights\n• Reframing the bar isn't lowering it. It's asking whether you're measuring the risk you actually care about.\n• A market nobody has measured is easy to dismiss. Sizing it can make it undeniable.\n• Diligence rules like large GP commitments can screen out strong...","thumbnail_url":"https://img.transistorcdn.com/ZnB7esk3hxfFIoNnysnaXcdcNStXN6Vgj5GFpWxsycY/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9hZTZl/N2FhYTdlYjFlYjNj/MjZjZjU3MGMxYWM0/YWVlZC5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}